Clinical significance of Helicobacter infection in children
Insights
Childhood Helicobacter pylori infection is common globally, especially in developing nations. Early treatment is crucial as it
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Epidemiology
Background:
- Helicobacter pylori (H. pylori) infection is a primary cause of chronic gastritis, peptic ulcers, and gastric cancer in adults.
- H. pylori infection is predominantly acquired during childhood, with prevalence varying significantly by socioeconomic status and geographic region.
- While often asymptomatic in children, H. pylori infection is linked to duodenal ulcer disease and is a risk factor for gastric carcinoma.
Purpose of the Study:
- To investigate the epidemiological characteristics of H. pylori infection in children.
- To understand the implications of childhood H. pylori acquisition on long-term health outcomes.
- To evaluate current treatment strategies and identify the need for clinical guidelines in pediatric H. pylori management.
Main Methods:
- Review of epidemiological data on H. pylori prevalence in pediatric populations worldwide.
- Analysis of the association between H. pylori infection and gastrointestinal diseases in children.
- Evaluation of a specific treatment regimen for H. pylori in children.
Main Results:
- H. pylori prevalence in children ranges from 10% in developed countries to 80-100% in developing countries.
- Infection in children is a significant risk factor for developing gastric carcinoma later in life.
- A one-week triple therapy regimen (colloidal bismuth subcitrate, metronidazole, clarithromycin) shows efficacy, emphasizing the importance of patient compliance.
Conclusions:
- Childhood H. pylori infection is a critical public health concern with long-term sequelae.
- Further research is needed to determine optimal treatment guidelines and address unanswered epidemiological questions.
- A consensus on the necessity and approach to treating H. pylori in children is urgently required.
Abstract:
Helicobacter pylori infection of the gastric mucosa causes chronic gastritis and is associated with peptic ulcer disease and gastric carcinoma. These are conditions which usually occur in adult life. However, H. pylori is an infection which is mainly acquired in childhood. The overall prevalence of H. pylori in children is 10% in developed countries but can be as high as 30-40% in children from lower socio-economic groups. In developing countries, the prevalence of H. pylori in children ranges from 80-100%. H. pylori gastritis does not appear to be associated with symptoms in children in the absence of duodenal ulcer disease. H. pylori infection is present in the vast majority of children with duodenal ulcer disease and, as in adults, eradication of the organism results in long-term healing of duodenal ulceration. H. pylori infection acquired in childhood is now considered to be a significant risk factor for the development of gastric carcinoma. The World Health Organization has classified H. pylori as a Group 1 carcinogen. Specific epidemiological questions which need to be answered in children include the age at which infection is acquired, specific risk factors for infection, the mode of transmission and the risk of reinfection following treatment. Recently, a one week treatment regimen using colloidal bismuth subcitrate, metronidazole and clarithromycin has been shown to be effective in treating children, but compliance is important. Currently there are no guidelines on the need to treat children and a consensus is urgently required on this issue.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Amebiasis
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Complications
